3M and NIBRT Collaborate
3M, the science-based technology company, has commissioned the National Institute for Bioprocessing Research and Training (NIBRT) to conduct in-depth research into their Emphaze AEX Hybrid Purifier, a single use plug and play filter matrix.
3M, the science-based technology company, has commissioned the National Institute for Bioprocessing Research and Training (NIBRT) to conduct in-depth research into their Emphaze AEX Hybrid Purifier, a single use plug and play filter matrix.
The collaborative project will be split into two studies, carried out independently by NIBRT, with results expected early 2018. The first study, which is currently underway, is examining the effect of chromatographic clarification on host cell DNA, and the specific type and quantity of host cell proteins removed prior to downstream processing.
The second study will build on the first study and investigate if gains in performance are possible from optimizing the load conditions for the device.
Dr. Jonathan Bones, the Principal Investigator at NIBRT, highlighted the research as important for investigating the value of the Emphaze AEX Hybrid Purifier to the biotechnology industry.
“I am excited to be working with 3M on this project,” said Bones.
For more information please visit: www.3m.com
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.
